Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net loss	$ (36,854)	$ (35,783)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	4,354	2,419
Stock-based compensation	33,739	32,255
Amortization of deferred commissions	15,971	11,353
Non-cash operating lease costs	2,482	2,476
Amortization of debt issuance costs	510	887
Amortization of premium and accretion of discount on marketable securities, net	882	99
Deferred income taxes, net	(9,134)	0
Remeasurement of options to repurchase common stock	2,091	0
Changes in assets and liabilities:
Accounts receivable	86,206	65,129
Prepaid expenses and other short-term assets	(2,547)	11,077
Deferred commissions	(19,748)	(13,603)
Other long-term assets	(11,253)	12
Trade payables	5,026	1,961
Accrued expenses and other short-term liabilities	(14,081)	(16,728)
Deferred revenues	(2,785)	5,988
Other long-term liabilities	183	458
Net cash provided by operating activities	55,042	68,000
Cash flows from investing activities:
Proceeds from maturities of marketable securities	93,840	56,000
Proceeds from sales of marketable securities	90,250	0
Investment in marketable securities	0	(57,654)
Proceeds from short-term and long-term deposits	62,570	34,174
Investment in short-term and long-term deposits	(63,691)	(36,289)
Acquisitions, net of cash acquired	(113,619)	(18,584)
Purchases of property and equipment	(4,971)	(2,339)
Capitalized internal-use software	(1,048)	(325)
Net cash provided by (used in) investing activities	63,331	(25,017)
Cash flows from financing activities:
Repurchase of common stock	(135,000)	(61,264)
Proceeds from options to repurchase common stock	2,900	0
Proceeds from employee stock plans	7,970	7,163
Taxes paid related to net share settlement of equity awards	(17,386)	(21,360)
Net cash used in financing activities	(141,516)	(75,461)
Decrease in cash and cash equivalents	(23,143)	(32,478)
Cash and cash equivalents at beginning of period	202,482	185,585
Cash and cash equivalents at end of period	179,339	153,107
Supplemental disclosure of cash flow information:
Cash paid for income taxes	288	894
Cash paid for interest	2,300	3,938
Supplemental disclosure of non-cash activities:
Lease liabilities arising from obtaining right-of-use assets	1,254	366
Liability related to acquisition holdback	0	3,502
Tax liability related to net share settlement of equity awards	0	5,087
Common stock issued for debt conversion	$ 0	$ 1